A July 2024 Harvard study found diabetes patients prescribed semaglutide were over four times likely to develop NAION, while those prescribed it for weight loss were over seven times likely to develop this condition
Minisha Sood, MD, a board-certified endocrinologist at Northwell Lenox Hill Hospital in New York City, doesnt recommend Vyvanse for the sole purpose of weight loss, but she says weight loss is sometimes an unintentional side effect of the medication
( a-c ) Representative histological images from of sections with antibody labeling for mCherry (magenta) or DCZ-induced Fos (green) and DAPI (blue) from Control (n = 4 mice) ( a ), Gs-Dreadd (n = 4 mice) ( b ), or Gq-Dreadd (n = 6 mice) ( c ) mice
Frequently Asked Questions Can I adjust my semaglutide dose myself, or does my prescriber decide
EpsteinBarr virus in systemic autoimmune diseases